Correlation of atrial natriuretic peptide and cyclic guanosine monophosphate plasma concentrations in patients with heart disorders during rest and exercise.
The concentration of atrial natriuretic peptide was measured in order to evaluate its importance in patients suffering from a variety of cardiac diseases. There was a correlation between plasma concentrations of atrial natriuretic peptide and its "second messenger" cyclic guanosine monophosphate (cGMP) in all of the cases examined. We investigated the relationship between atrial natriuretic peptide and cGMP plasma concentrations during rest and exercise in comparison with the scintigraphically assessed left- and right-ventricular ejection fraction in patients with chronic heart disease (n = 20), and after orthotopic heart transplantation (n = 16); plasma concentrations were also measured in healthy controls (n = 14). Atrial natriuretic peptide and cGMP concentrations showed a similar correlation during rest and exercise with r = 0.74 and r = 0.81, respectively. With the exception of patients after heart transplantation, a significant negative correlation was seen between the left ventricular ejection fraction and atrial natriuretic peptide or cGMP plasma concentrations during rest conditions (r = 0.76 or 0.58, respectively). No correlation was apparent between plasma concentrations of atrial natriuretic peptide or cGMP and the left- or right ventricular ejection fraction during exercise. The concentrations of atrial natriuretic peptide and cGMP in plasma differed significantly between healthy controls and patients during rest and exercise. It is noteworthy that atrial natriuretic peptide and cGMP concentrations were markedly higher in patients after heart transplantation than in patients suffering from chronic heart disease. Our results indicate that plasma atrial natriuretic peptide and cGMP concentrations are sensitive markers of cardiac impairment.
Szekeres
T
T
Institut für Medizinische Chemie, Universität Wien, Austria.
Artner-Dworzak
E
E
Puschendorf
B
B
Fritzer
M
M
Havel
M
M
Gassner
A
A
Fridrich
L
L
D009320:Atrial Natriuretic Factor / Q000097:blood*; D015415:Biomarkers; D006152:Cyclic GMP / Q000097:blood*; D015444:Exercise / Q000502:physiology; D006331:Heart Diseases / Q000097:blood* / Q000175:diagnosis / Q000503:physiopathology; D016027:Heart Transplantation / Q000502:physiology; D006801:Humans; D013318:Stroke Volume; D016277:Ventricular Function, Left; D016278:Ventricular Function, Right
D015415:Biomarkers; D009320:Atrial Natriuretic Factor; D006152:Cyclic GMP